Related Experiment Videos
Exenteration as palliation for patients with advanced pelvic malignancy
C R Woodhouse1, R O Plail, P E Schlesinger
1Department of Urology, Royal Marsden Hospital, London, UK.
British Journal of Urology
|September 1, 1995
Summary
Pelvic exenteration can offer significant palliation for advanced pelvic tumors. Careful patient selection and multi-specialty care are crucial for successful outcomes in palliative surgery.
Area of Science:
- Oncology
- Surgical Oncology
- Palliative Care
Background:
- Advanced and recurrent pelvic tumors present significant challenges in management.
- Palliative surgical interventions aim to improve quality of life and manage severe symptoms.
Purpose of the Study:
- To evaluate the role and effectiveness of pelvic exenteration in palliating advanced and recurrent pelvic tumors.
- To assess survival and quality of life outcomes following palliative pelvic exenteration.
Main Methods:
- Retrospective review of patient records for those referred for palliative exenteration.
- Analysis of 14 patients undergoing laparotomy for pelvic exenteration, with 10 proceeding to total or anterior exenteration.
Main Results:
- Eight patients experienced excellent or good palliation, with four alive and tumor-free at a mean of 17 months.
- Four patients were alive with symptoms controlled but evidence of malignancy at a mean of 19 months.
- Two patients derived no benefit and died within 7 months; exenteration was abandoned in four others.
Conclusions:
- Aggressive pelvic surgery, specifically pelvic exenteration, can be valuable for palliation in selected patients.
- Careful patient selection and multidisciplinary team involvement are essential for optimizing outcomes in palliative pelvic surgery.